COSMO PHARMACEUTICALS N.V.

(COPN)
  Bericht
Verzögert Swiss Exchange  -  19/05 17:30:34
52.80 CHF   +3.33%
03.05.Cosmo weitet Vertriebsvereinbarung mit Medtronic für Eleview aus
AW
03.05.Cosmo Pharmaceuticals und Medtronic unterzeichnen weltweiten Vertriebsvertrag für Eleview
MT
03.05.Cosmo verkündet erweiterung der vereinbarung mit medtronic für eleview(r) auf alle länder ausser kanada
EQ
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über COSMO PHARMACEUTICALS N.V.
03.05.COSMO : Medtronic distribuera l'Eleview partout sauf au Canada
03.05.Cosmo Pharmaceuticals, Medtronic Sign Global Distribution Deal for Eleview
03.05.Cosmo announces expanding the agreement with medtronic for eleview(r) to all countries ..
03.05.Cosmo Pharmaceuticals N.V. Announces Expanding the Agreement with Medtronic for Eleview..
02.05.COSMO PHARMACEUTICALS N : Notification of number of shares
15.04.COSMO PHARMACEUTICALS N : Convening notice
15.04.COSMO PHARMACEUTICALS N : Explanatory notes
15.04.COSMO PHARMACEUTICALS N : Notification of number of shares
15.04.COSMO PHARMACEUTICALS N : Proposed Amendments to the Remuneration Policy
15.04.COSMO PHARMACEUTICALS N : Written proxy
23.03.Cosmo pharmaceuticals - full-year results 2021, confirms beating guidance
23.03.TRANSCRIPT : Cosmo Pharmaceuticals N.V., 2021 Earnings Call, Mar 23, 2022
23.03.Cosmo a renoué avec les profits l'an dernier
23.03.Cosmo Pharmaceuticals To Propose Dividend After Swing To FY21 Profit
23.03.Cosmo announces full-year results 2021; confirms beating guidance
23.03.Cosmo Pharmaceuticals N.V. Reports Earnings Results for the Full Year Ended December 31..
23.03.COSMO PHARMACEUTICALS N : Annual Report 2021
23.03.COSMO PHARMACEUTICALS N : Full-year results 2021
18.03.Cosmo Pharmaceuticals - FIRST U.S. TRIAL USING GI GENIUS INTELLIGENT ENDOSCOPY MODULE S..
18.03.COSMO : une étude prouve l'efficacité de GI Genius pour détecter les polypes
18.03.Cosmo Pharmaceuticals Partner Medtronic Says GI Genius Endoscopy Lowers Colorectal Poly..
18.03.COSMO PHARMACEUTICALS N : First U.S. trial using GI Genius™ intelligent endoscopy mo..
18.03.First U.S. trial using GI Genius(TM) intelligent endoscopy module shows 50% reduction  ..
16.03.COSMO PHARMACEUTICALS N : Invitation to Cosmo's full-year 2021 results and 2022 outlook we..
16.03.Invitation to Cosmo's full-year 2021 results and 2022 outlook webcast presentation on 2..
02.03.COSMO PHARMACEUTICALS N : 2022 Credit Suisse London Global Healthcare Conference
25.02.Cassiopea Gets SIX Swiss Exchange Nod to Delist After Cosmo Pharmaceuticals Buyback
15.02.Cosmo songe à rémunérer régulièrement ses actionnaires
15.02.Cosmo Pharmaceuticals Upgrades FY21 Outlook After Licensing Of Acne Treatment
15.02.Cosmo Pharmaceuticals Announces 2021 preliminary results beating guidance, return to di..
15.02.Cosmo Pharmaceuticals N.V. Proposes Cash Dividend
15.02.Cosmo Pharmaceuticals N.V. Provides Earnings Guidance for the Year 2022
04.02.Cassiopea prévoit de se retirer de la Bourse début mars
04.02.Cassiopea To Delist From Swiss Bourse In March After Takeover By Cosmo Pharmaceuticals
20.01.Cassiopea prépare la décotation de son titre à la Bourse suisse
20.01.Cassiopea to Delist Shares from Swiss Bourse After Takeover by Cosmo
06.01.BOURSE ZURICH : la chasse aux records reprend avant la fin d'année
06.01.BOURSE ZURICH : hésitante à l'entame de la dernière séance de l'année
06.01.Départ du responsable scientifique de Cosmo Pharmaceuticals
2021BOURSE ZURICH : le SMI termine l'année sur un nouveau sommet historique en séance
2021Cosmo Pharmaceuticals Announces Hiring of Head of Investor Relations and Senior Leaders..
2021Cosmo Pharmaceuticals N.V. Announces Executive Changes
2021BOURSE ZURICH : le SMI termine la semaine dans le rouge
2021BOURSE ZURICH : le SMI accentue ses pertes à l'approche de la mi-journée
2021BOURSE ZURICH : ouverture dans le rouge au lendemain d'une journée de folie
2021COSMO : la reprise de Cassiopea est désormais sous toit
2021Cosmo Closes Public Exchange Offer For Cassiopea After Amassing 97% Stake
2021Cosmo pharmaceuticals n.v. and cassiopea s.p.a announce settlement of public exchange o..
2021Cosmo détient 93,4% de Cassiopea à l'issue de son offre de reprise
2021Cosmo pharmaceuticals n.v. and cassiopea s.p.a. publish definitive final results of pub..
2021Cosmo Pharmaceuticals Secures Over 93% Stake in Cassiopea at Tender Closing
2021COSMO PHARMACEUTICALS N.V. and Cassiopea S.p.a. PUBLISH PROVISIONAL final RESULTS OF PU..
2021Cosmo Pharmaceuticals' GI Genius Device Cuts Adenoma, Polyp Miss Rate in Colonoscopy
2021DETECT study shows AI assistance using GI Genius(TM) reduces missed polyp rate by nearl..
2021Cosmo Pharmaceuticals N.V. Detects Study Shows AI Assistance Using GI Genius? Reduces M..
2021Cosmo clôt la reprise de Cassiopea
2021Cosmo Pharmaceuticals to Start Additional Acceptance Period in Cassiopea Offer
2021COSMO PHARMACEUTICALS N : Credit Suisse Equity Forum 2021
2021Cosmo pharmaceuticals n.v. and cassiopea s.p.a. publish definitive interim results of p..
2021Cosmo obtient une homologation au Canada pour GI Genius
2021Cosmo Pharmaceuticals' Endoscopy Aid Device Secures Canadian Regulatory Approval
2021Cosmo announces regulatory approval of GI Genius(TM) in Canada
2021Cosmo Announces Regulatory Approval of GI Genius? in Canada
2021Cosmo Pharmaceuticals Wins Shareholders Nod For Cassiopea Stake Deal
2021COSMO : les actionnaires ouvrent la voie pour la reprise de Cassiopea
2021Cosmo Pharmaceuticals' Shareholders approve all Agenda Items at Extraordinary General M..
2021Cosmo Pharmaceuticals N.V. Appoints Alexis De Rosnay as Non-Executive Member of the Boa..
2021Cosmo détient désormais 87,4% de Cassiopea
2021Cosmo Pharmaceuticals Raises Cassiopea Stake To Over 87%
2021COSMO PHARMACEUTICALS N : Jefferies London Healthcare Conference 2021
2021Cosmo pharmaceuticals n.v. and cassiopea s.p.a. publish provisional interim results of ..
2021Alexis de Rosnay - Curriculum vitae
2021EGM November 16, 2021 – Written Proxy
2021Notification of number of shares
2021Explanatory notes
1  2  3  4  5  6  7Weiter
Anstehende Termine für COSMO PHARMACEUTICALS N.V.